China launches a “Two-Invoice System” to simplify the drug distribution chain and reduce prices and corruption in the healthcare sector. The new policy may bring substantial compliance and business model challenges for pharmaceutical companies
In a rare move, the Texas judge rewrote the plea agreement to name his own independent corporate monitor in the ZTE sanctions case, substituting the DOJ's authority with the court's
Six key pieces of legislation that would allow the U.S. to confront China if President Trump decides to up the ante—and risk world economic instability
